NYXH — Nyxoah SA

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1857190 · Belgium
Last close
$1.59
Market Cap
$158.88M
52W High
$3.64
52W Low
$1.26
ADV30
431,061
Next earnings
2026-08-05
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 6,372,000 3,638,000 -20,503,000 -15,944,000 97,598,000 12,934,000 61,727,000
Dec 2025 5,644,000 3,625,000 -18,259,000 -23,513,000 118,471,000 30,001,000 69,342,000
Sep 2025 1,972,000 1,193,000 -24,195,000 -23,580,000 93,599,000 10,869,000 42,645,000
Jun 2025 1,340,000 850,000 -19,850,000 -20,607,000 116,470,000 22,729,000 43,073,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-59,359,000
Investing CF
$785,000
Financing CF
$71,767,000
CapEx
$-3,783,000
Dividends Paid
$0
Buybacks
EPS Diluted TTM
$-2.37
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-306,029,000
Inventory
$4,660,000
Receivables
$7,578,000
ST Investments
$18,000,000
EBIT TTM
$-87,385,000
Pretax Income TTM
$-89,076,000
Interest Exp TTM
$1,691,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$15,328,000
EBITDA
$-82,043,000
Free Cash Flow
$-45,774,752
Enterprise Value
$79,132,600
Total Cash
$25,934,000
Total Debt
$36,080,000
Shares Out
99,926,284
Trailing EPS
$-2.48
Book Value
$0.95
ROE
-130.0%
ROA
-44.6%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 10,020,000 -82,942,000 -90,085,000 118,471,000 69,342,000 -68,979,000
Dec 2024 4,521,000 -58,809,000 -59,236,000 158,406,000 45,152,000 -49,226,000
Dec 2023 4,348,000 -45,102,000 -43,212,000 124,157,000 26,135,000 -44,778,000
Dec 2022 3,084,000 -32,499,000 -31,225,000 146,071,000 25,747,000 -28,756,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-1.33

Peers — same industry

TickerNameMarket CapLastDaily %
INGN Inogen Inc $172.46M $6.37
STXS Stereotaxis, Inc. $173.97M $1.78
APYX Apyx Medical Corp $176.29M $4.21
INFU InfuSystem Holdings, Inc $176.59M $8.75
KRMD KORU Medical Systems, Inc. $178.22M $3.88

News headlines (Yahoo Finance, 1h cache)

Publication relating to transparency notifications
2026-06-17 20:30 · Yahoo
Nyxoah Receives $15 Million from the European Investment Bank
2026-06-17 20:05 · Yahoo
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
2026-06-15 20:05 · Yahoo
Information on the total number of voting rights and shares
2026-06-10 21:00 · Yahoo
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
2026-06-10 20:30 · Yahoo
Nyxoah Announces Closing of Underwritten Public Offering
2026-06-10 20:05 · Yahoo
Why Is NYXH Stock Falling Today?
2026-06-05 16:58 · Yahoo
Nyxoah Announces Pricing of $95 Million Underwritten Public Offering
2026-06-05 15:25 · Yahoo
Nyxoah Announces Proposed Offering of Ordinary Shares
2026-06-04 20:02 · Yahoo
Nyxoah Enters New Chapter of Long Term Value Creation
2026-06-04 20:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.